Package 51655-432-52

Brand: alfuzosin hydrochloride

Generic: alfuzosin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51655-432-52
Digits Only 5165543252
Product NDC 51655-432
Product ID 51655-432_490ec676-81a7-6ba1-e063-6394a90a5039
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-432-52)

Marketing

Marketing Status
Marketed Since 2020-09-09
Brand alfuzosin hydrochloride
Generic alfuzosin hydrochloride
Sample Package No

Linked Drug Pages (1)

Alfuzosin Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "490ec676-81a7-6ba1-e063-6394a90a5039", "openfda": {"unii": ["75046A1XTN"], "rxcui": ["861132"], "spl_set_id": ["f2f42c98-4118-5f70-e053-2a95a90add02"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-432-52)", "package_ndc": "51655-432-52", "marketing_start_date": "20200909"}], "brand_name": "Alfuzosin Hydrochloride", "product_id": "51655-432_490ec676-81a7-6ba1-e063-6394a90a5039", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "51655-432", "generic_name": "Alfuzosin Hydrochloride", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alfuzosin Hydrochloride", "active_ingredients": [{"name": "ALFUZOSIN HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA079057", "marketing_category": "ANDA", "marketing_start_date": "20200909", "listing_expiration_date": "20271231"}